Final Fantasy 7 Rebirth Patch Quietly Fixes Confusing Wording On Its Final Boss Fight's Retry Menu
Final Fantasy 7 Rebirth patch changes confusing phrasing on final battle retry menu screen.
Source: ign.com
📰 Current Phase News
Current Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Current Phase. Real-time updates on events, politics, business and more.
Endless Solar Corporation Limited Cool Solar project update -November 30, 2023 at 12:55 am EST
The Endless Solar Corporation Limited is pleased to announce receipt of the Endless Energy Solutions - Project Update, from EES Chairman Mr. Andrew Hynson. Engineering Prototype The engineering...
Source: marketscreener.com
IslandWolrd (Name For Now) - A 3D Java Survival Game Written In Java Thread
Discuss the topic "IslandWolrd (Name For Now) - A 3D Java Survival Game Written In Java" in the Development Banter Official Forums.
Development Phases Minium Requirements Current Phase Islandwolrd Name For Nowa 3d Java Survival Game Written In Development Banter
Source: indiedb.com
IslandWolrd (Name For Now) - A 3D Java Survival Game Written In Java Thread
Discuss the topic "IslandWolrd (Name For Now) - A 3D Java Survival Game Written In Java" in the Development Banter Official Forums.
Development Phases Minium Requirements Current Phase Islandwolrd Name For Nowa 3d Java Survival Game Written In Development Banter
Source: moddb.com
ESSA Pharma Inc. Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat
ESSA Pharma Inc. announced the presentation of updated dose escalation data from its Phase 1/2 study evaluating masofaniten in combination with enzalutamide at the 30th Annual Prostate Cancer...
Andrew Laccetti Prostate Cancer Foundation Scientific Drug Administration Memorial Sloan Kettering Cancer Center Essa Pharma Inc Enz Alone
Source: marketscreener.com
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat
/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for...
United States British Columbia David Parkinson Andrew Laccetti Drug Administration Memorial Sloan Kettering Cancer Center
Source: prnewswire.com
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat
Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPC Across all cohorts of patients including those recently...
British Columbia United States Andrew Laccetti David Parkinson Prostate Cancer Foundation Scientific Drug Administration
Source: marketscreener.com
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat
Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPC Across all cohorts of patients including those recently...
United States British Columbia Andrew Laccetti David Parkinson Drug Administration Prostate Cancer Foundation Scientific
Source: marketscreener.com
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the European Society of Medical Oncology 2023 Congress
Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPC Across all cohorts of patients including those recently...
United States British Columbia Andrew Laccetti David Parkinson Digital Program European Society Of Medical Oncology
Source: marketscreener.com
ESSA Pharma Announces Initiation of Phase 2 Study Evaluating Masofaniten (EPI-7386) in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for...
British Columbia United States David Parkinson Andrewl Laccetti Prostate Cancer Clinical Trials Working Group Drug Administration
Source: prnewswire.com